These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5149499)

  • 1. [Rational use of antibiotics. Socioeconomic problems].
    Cah Med; 1971 Dec; 12(17):1538-44. PubMed ID: 5149499
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical economics and optimal antibiotic therapy].
    Bergogne-Berezin E
    Biomed Pharmacother; 1982; 36(8-9):393-5. PubMed ID: 7182024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of commonly used oral antimicrobials for acute infections.
    Med Lett Drugs Ther; 1971 Apr; 13(7):26-7. PubMed ID: 5559658
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotics for restricted use].
    Klemola E
    Duodecim; 1970; 86(4):252-7. PubMed ID: 5419256
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost analysis of antibiotics in pediatric practice.
    Gupta AP
    Indian Pediatr; 1983 Jul; 20(7):531-2. PubMed ID: 6654490
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for cost evaluation of new antibiotics.
    Feldman M; Moura R; Sharon D; Daly J; Lynch M; Worthington M
    Arch Intern Med; 1989 Jul; 149(7):1698. PubMed ID: 2742447
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiotics and health care economics].
    Modai J; Droulers AM
    Soins; 1981 Mar; 26(6):38-9. PubMed ID: 6910261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the frequency of antibiotics use per day among inpatients in 151 hospitals in 2003].
    Wu AH; Ren N; Wen XM; Xu XH; Li J; Yi XY; Huang X; Guo YH;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):451-4. PubMed ID: 16185465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotics for common respiratory infections.
    Owen S
    Aust Fam Physician; 1995 Jul; 24(7):1368-9. PubMed ID: 7661790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Self-medication with antibiotics. The URANO Group].
    González Núñez J; Ripoll Lozano MA; Prieto Prieto J
    Med Clin (Barc); 1998 Jul; 111(5):182-6. PubMed ID: 9732836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacoeconomics of infection in the intensive care unit].
    Grau S; Alvarez-Lerma F
    Rev Esp Quimioter; 2008; 21 Spec No 1():26-34. PubMed ID: 18752077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs.
    Murray MD; Kohler RB; Main JW
    Hosp Formul; 1988 Jun; 23(6):518-24, 529-30. PubMed ID: 10287850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The distribution and consumption of subsidized medicine. A preliminary account to illustrate the consequences of reduction of the subsidies for medicine].
    Hilden J
    Ugeskr Laeger; 1974 Nov; 136(45):2539-45. PubMed ID: 4417068
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 19. High quality drugs at reduced cost for hospital patients.
    Guenther J; Pio M; Lohrenz FN
    Wis Med J; 1968 May; 67(5):274-5. PubMed ID: 5654936
    [No Abstract]   [Full Text] [Related]  

  • 20. The Maximum Allowable Cost program--some marketing consequences.
    Gosselin RA
    Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.